Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Plaque Psoriasis Clinical Trials Analysis Overview
The Plaque Psoriasis (Psoriasis Vulgaris) clinical trial report consists of 2018 trials. The report provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. Our study also includes top-line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Our analysts have further provided an overview of trial numbers and their average enrolment in top countries conducted across the globe, in this report. Furthermore, our review of the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial landscape entails coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also includes the names of prominent sponsors involved with conducting the Plaque Psoriasis (Psoriasis Vulgaris) clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· Germany · Canada · China · The UK · Poland |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Novartis AG
· AbbVie Inc · LEO Foundation · Johnson & Johnson · Pfizer Inc · Amgen Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Segmentation by Regions and Countries
North America led the Plaque Psoriasis (Psoriasis Vulgaris) clinical trials landscape with more than 30% of the clinical trials conducted there as of November 2023
The key regions considered for Plaque Psoriasis (Psoriasis Vulgaris) clinical trials analysis are Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America.
In a country-wise analysis, as of November 2023, the US accounted for the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials, followed by Germany and Canada.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, Canada has the highest proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology clinical trials as of November 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, India has the highest proportion of Plaque Psoriasis (Psoriasis Vulgaris) to Immunology clinical trials as of November 2023.
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Plaque Psoriasis (Psoriasis Vulgaris) clinical trials are company, institution, and government. As of November 2023, the company sponsor type dominated the Plaque Psoriasis (Psoriasis Vulgaris) clinical trials share, followed by institution.
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Analysis by Sponsor Types, 2023 (%)
Buy the Full Report for More Sponsor Type Insights into Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials - Competitive Landscape
In 2023, Novartis AG conducted the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials
A few of the leading sponsors for Plaque Psoriasis (Psoriasis Vulgaris) clinical trials are:
- Novartis AG
- AbbVie Inc
- LEO Foundation
- Johnson & Johnson
- Pfizer Inc
- Amgen Inc
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More about the Leading Players of Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials
Segments Covered in the Report
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Country Outlook (2023)
- The US
- Germany
- Canada
- China
- The UK
- Poland
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies regarding investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the global clinical trials market which helps identify key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
AbbVie Inc
LEO Foundation
Johnson & Johnson
Pfizer Inc
Amgen Inc
Eli Lilly and Co
Bristol-Myers Squibb Co
ICON Plc
C. H. Boehringer Sohn AG & Co KG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials?
North America accounted for the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials as of November 2023.
-
Which country conducted the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials?
The US conducted the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials as of November 2023.
-
The US conducted the highest number of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials as of November 2023.
Company was the most prominent sponsor type for Plaque Psoriasis (Psoriasis Vulgaris) clinical trials.
-
Who are the leading sponsors of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials?
A few of the leading sponsors of Plaque Psoriasis (Psoriasis Vulgaris) clinical trials are Novartis AG, AbbVie Inc, LEO Foundation, Johnson & Johnson, Pfizer Inc, and Amgen Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.